The cannabis plant is a master chemist, producing a dazzling array of compounds that interact with the human body in remarkable ways. Among its 500+ chemical constituents, cannabinoids stand out as the primary drivers of cannabis’s therapeutic effects. These naturally occurring compounds work by engaging with our endocannabinoid system – a complex network of receptors found throughout the body that helps regulate everything from mood and appetite to pain and inflammation.
For decades, scientific understanding of cannabis was limited by legal restrictions and social stigma. Now, as barriers fall and research accelerates, we’re discovering that the cannabis plant’s true power lies not just in its famous THC and CBD, but in a vast family of related compounds, each with its own unique profile and potential benefits. From the sedating effects of CBN to the appetite-suppressing properties of THCV, from the neuroprotective qualities of THCA to the remarkable potency of the recently discovered THCP, these cannabinoids represent a treasure trove of therapeutic possibilities.
This comprehensive guide introduces you to the 20 most significant cannabinoids currently known to science, complete with their discovery dates, effects, and medical applications. Whether you’re a patient seeking alternatives, a healthcare provider expanding your knowledge, or simply curious about the science behind cannabis, understanding these compounds is your key to unlocking the plant’s full potential.
The Top 20 Cannabinoids You Want To Know About
T.L.D.R. –
The cannabis plant contains a remarkable array of chemical compounds called cannabinoids, each offering unique therapeutic properties that have revolutionized our understanding of plant-based medicine. Among the most significant discoveries are the “Big Six” cannabinoids that form the foundation of cannabis science. Leading this group is Δ9-THC, discovered in 1964, which produces the characteristic euphoric effects while also providing FDA-approved benefits for nausea and appetite loss. Its non-psychoactive counterpart, CBD, has taken the wellness world by storm since its discovery in 1940, offering anxiety relief and anti-inflammatory properties without intoxication. The group is rounded out by CBG (the “mother cannabinoid” from which others derive), CBN (the first cannabinoid ever isolated in 1896, known for its sedative effects), CBC (showing promise for brain health), and THCV (uniquely acting as an appetite suppressant).
Beyond the primary THC molecule, scientists have discovered an entire family of related compounds that offer variations on its effects. Δ8-THC provides a gentler experience with reduced anxiety, while the recently discovered THCP stunned researchers in 2019 with its potential to be 30 times more potent than regular THC at receptor binding. The raw form, THCA, exists in fresh cannabis and provides powerful anti-inflammatory benefits without any psychoactive effects until heated. When THC is processed by the liver, it creates 11-OH-THC, the metabolite responsible for the intense and long-lasting effects of edible cannabis products.
The CBD family represents a therapeutic revolution, offering powerful medical benefits without psychoactive effects. CBDA, the raw precursor to CBD, demonstrates strong anti-nausea properties that may benefit cancer patients. CBDV shows enhanced anticonvulsant properties and is being extensively studied for epilepsy and autism spectrum disorders. The 2019 discovery of CBDP alongside THCP suggests that more potent versions of familiar cannabinoids may exist throughout the plant, opening new avenues for treatment at lower doses.
Among the lesser-known but increasingly important cannabinoids are compounds like CBL, CBE, and CBT. While these “minor” cannabinoids appear in smaller quantities, their unique molecular structures suggest novel mechanisms of action that could address specific medical conditions. CBL forms when CBC degrades in light, maintaining anti-inflammatory properties, while CBT’s unusual three hydroxyl groups make it structurally distinct from other cannabinoids, hinting at unique therapeutic applications yet to be discovered.
The acid precursors deserve special recognition as the foundation of cannabinoid chemistry. CBGA, truly the “mother of all cannabinoids,” serves as the chemical precursor that enzymatically transforms into THCA, CBDA, and CBCA. These acid forms aren’t merely inactive precursors waiting to be heated; they possess their own therapeutic properties. CBGA shows antibacterial and anti-inflammatory effects, while CBCA demonstrates antifungal properties, suggesting that raw cannabis preparations may have medical value beyond their activated forms.
Recent discoveries highlight how much remains unknown about cannabis chemistry. Cannabimovone (CBM), discovered in 2010, has a structure unlike typical cannabinoids, suggesting it may work through entirely different biological pathways. The 2019 discoveries of THCP and CBDP revealed that cannabis can produce compounds far more potent than previously imagined, potentially allowing for therapeutic effects at much lower doses and opening new possibilities for pharmaceutical development.
The medical applications of these cannabinoids span an impressive range of conditions. From FDA-approved uses for epilepsy and chemotherapy-induced nausea to emerging applications for neurodegenerative diseases, metabolic disorders, and antibiotic-resistant infections, cannabinoids offer hope for conditions that have proven difficult to treat with conventional medicine. The anti-inflammatory properties shared by many cannabinoids make them particularly promising for chronic pain conditions, while the neuroprotective effects of compounds like CBD and THCA suggest potential for treating diseases like Alzheimer’s and Parkinson’s.
Perhaps most significantly, this diverse array of cannabinoids points toward a future of personalized cannabis medicine. Rather than relying on THC and CBD alone, patients may soon benefit from tailored cannabinoid profiles designed for specific conditions and individual biochemistry. The concept of the “entourage effect” suggests these compounds work synergistically, with combinations potentially more effective than isolated molecules. As research continues and new cannabinoids are discovered, cannabis is evolving from a simple intoxicant to a sophisticated pharmacological toolkit, offering targeted therapeutic options for an ever-expanding range of medical conditions.
The Big Six: Major Cannabinoids
These are the heavy hitters of the cannabis world – the most abundant and well-studied cannabinoids that form the foundation of cannabis medicine. From THC’s psychoactive effects to CBD’s versatile therapeutic properties, these six compounds are responsible for most of cannabis’s primary effects and have paved the way for our understanding of how cannabinoids work in the human body. Each has been extensively researched and offers proven medical benefits.
1. Δ9-Tetrahydrocannabinol (Δ9-THC)
Discovered: 1964 by Raphael Mechoulam
Effects: The star of the show, THC is the primary psychoactive compound responsible for cannabis’s euphoric effects. Beyond the high, it offers pain relief, appetite stimulation, and anti-inflammatory properties.
Medical Applications: FDA-approved for nausea and appetite loss, widely used for chronic pain, glaucoma, and muscle spasticity.
2. Cannabidiol (CBD)
Discovered: 1940 by Roger Adams
Effects: The non-psychoactive counterpart to THC, CBD has taken the wellness world by storm. It’s anxiolytic, anti-inflammatory, and neuroprotective without causing intoxication.
Medical Applications: FDA-approved for certain types of epilepsy (Epidiolex), extensively used for anxiety, inflammation, and pain management.
3. Cannabigerol (CBG)
Discovered: 1964
Effects: Often called the “mother cannabinoid” because it’s the precursor to THC and CBD. Non-psychoactive with potential antibacterial and anti-inflammatory effects.
Medical Applications: Shows promise for inflammatory bowel disease, glaucoma, bladder dysfunction, and potentially fighting antibiotic-resistant bacteria.
4. Cannabinol (CBN)
Discovered: 1896 (first cannabinoid ever isolated)
Effects: Mildly psychoactive and notably sedative. CBN forms when THC degrades, which is why older cannabis tends to be more sleep-inducing.
Medical Applications: Emerging as a natural sleep aid, with additional potential as an antibacterial agent and appetite stimulant.
5. Cannabichromene (CBC)
Discovered: 1966
Effects: Non-psychoactive with impressive anti-inflammatory properties. May promote neurogenesis (the growth of new brain cells).
Medical Applications: Shows potential for pain relief, mood enhancement, and acne treatment through its anti-inflammatory action.
6. Tetrahydrocannabivarin (THCV)
Discovered: 1973
Effects: A fascinating cannabinoid that acts as an appetite suppressant (opposite of THC) and may help with diabetes management. Psychoactive only at high doses.
Medical Applications: Being studied for weight management, diabetes treatment, and bone growth stimulation.
The THC Family: Variations On A Theme
While Δ9-THC gets most of the attention, the cannabis plant produces several related compounds that offer unique twists on THC’s effects. These variants include everything from the milder Δ8-THC to the incredibly potent THCP, as well as raw acid forms like THCA that provide therapeutic benefits without psychoactivity. Each member of the THC family has its own distinct profile, offering options for different therapeutic needs and tolerance levels.
7. Δ8-Tetrahydrocannabinol (Δ8-THC)
Discovered: 1966
Effects: The gentler cousin of Δ9-THC, offering similar benefits with less anxiety and paranoia. About 50-75% as potent as regular THC.
Medical Applications: Excellent for nausea reduction, anxiety management, and neuroprotection with a clearer-headed experience.
8. Tetrahydrocannabinolic Acid (THCA)
Discovered: 1969
Effects: The raw, non-psychoactive precursor to THC found in fresh cannabis. Converts to THC when heated (decarboxylation).
Medical Applications: Powerful anti-inflammatory and neuroprotective properties, being studied for epilepsy and neurodegenerative diseases.
9. Tetrahydrocannabiphorol (THCP)
Discovered: 2019
Effects: The new kid on the block with a stunning discovery – it’s potentially 30 times more potent than THC at binding to CB1 receptors.
Medical Applications: Still under investigation, but its potency suggests possible applications at much lower doses.
10. Δ10-Tetrahydrocannabinol (Δ10-THC)
Discovered: 1980
Effects: Mildly psychoactive with reportedly energizing and focusing effects, unlike the sedating nature of other THC variants.
Medical Applications: Being explored for daytime use, mood enhancement, and cognitive support.
The CBD Family: Non-Psychoactive Powerhouses
The CBD family represents the therapeutic side of cannabis without the high. These compounds have revolutionized medical cannabis by offering powerful healing properties that can be used by patients who need to remain clear-headed. From CBD’s broad-spectrum benefits to specialized variants like CBDV for epilepsy, this family of cannabinoids has opened doors for patients who previously couldn’t access cannabis medicine due to THC’s psychoactive effects.
11. Cannabidiolic Acid (CBDA)
Discovered: 1955
Effects: The raw form of CBD with its own unique benefits. Strong anti-inflammatory and antiemetic (anti-nausea) properties.
Medical Applications: Shows promise for nausea reduction and as a potential adjuvant in cancer treatment.
12. Cannabidivarin (CBDV)
Discovered: 1969
Effects: Similar to CBD but with enhanced anticonvulsant properties. Non-psychoactive and well-tolerated.
Medical Applications: Being studied extensively for epilepsy treatment and autism spectrum disorder symptom management.
13. Cannabidiphorol (CBDP)
Discovered: 2019
Effects: Like THCP, this is a more potent version of CBD, discovered alongside its THC counterpart.
Medical Applications: Early research suggests enhanced therapeutic effects compared to regular CBD.
The Supporting Cast: Minor But Mighty
Often overlooked but increasingly recognized for their importance, these minor cannabinoids may appear in smaller quantities but pack significant therapeutic potential. They demonstrate the incredible chemical diversity of cannabis, with unique structures that suggest novel mechanisms of action. As research progresses, many of these “minor” players may prove to be major therapeutic agents for specific conditions.
14. Cannabicyclol (CBL)
Discovered: 1967
Effects: Non-psychoactive degradation product of CBC formed when exposed to light. Represents the natural aging process of cannabis.
Medical Applications: Limited research, but shows potential anti-inflammatory effects.
15. Cannabielsoin (CBE)
Discovered: 1973
Effects: A metabolite of CBD that forms through specific transformation processes. Non-psychoactive.
Medical Applications: Still being investigated for potential therapeutic properties.
16. Cannabitriol (CBT)
Discovered: 1966
Effects: Structurally unique with three hydroxyl groups, making it distinct from other cannabinoids. Non-psychoactive.
Medical Applications: Limited research available, but its unique structure suggests potential novel applications.
The Acid Precursors: Raw Power
Before heat transforms them into their more familiar forms, cannabinoids exist as acids in the raw cannabis plant. These acid precursors aren’t just waiting to be activated – they have their own unique therapeutic properties. CBGA, in particular, serves as the chemical foundation from which most other cannabinoids are born, earning it the title of “mother cannabinoid.” Understanding these acids is key to appreciating cannabis in its natural state.
17. Cannabigerolic Acid (CBGA)
Discovered: 1964
Effects: The true “mother of all cannabinoids” – the precursor that transforms into THCA, CBDA, and CBCA through enzymatic processes.
Medical Applications: Shows antibacterial and anti-inflammatory effects in preliminary studies.
18. Cannabichromenic Acid (CBCA)
Discovered: 1996
Effects: The precursor to CBC with its own therapeutic potential. Non-psychoactive.
Medical Applications: Demonstrates antibacterial and antifungal properties.
The New Discoveries: Future Medicine
The most recent additions to the cannabinoid family showcase how much we still have to learn about cannabis. These compounds, discovered within the last decade or identified as important metabolites, represent the cutting edge of cannabinoid science. From CBM’s unique structure to 11-OH-THC’s role in edible potency, these discoveries are reshaping our understanding of how cannabis works and opening new avenues for therapeutic development.
19. Cannabimovone (CBM)
Discovered: 2010
Effects: Structurally different from typical cannabinoids, suggesting unique mechanisms of action. Non-psychoactive.
Medical Applications: Shows potential for anti-inflammatory effects and metabolic regulation.
20. 11-Hydroxy-Δ9-THC (11-OH-THC)
Discovered: 1970
Effects: The active metabolite of THC that forms in your liver. Often more potent than THC itself, contributing to the stronger effects of edibles.
Medical Applications: Responsible for many of THC’s therapeutic effects, particularly when cannabis is consumed orally.
Final Thoughts
The story of cannabinoids is far from over. With each passing year, researchers uncover new compounds and deeper insights into how these molecules interact with our bodies. The 20 cannabinoids profiled here represent just a fraction of cannabis’s chemical diversity, yet they offer a window into the plant’s extraordinary therapeutic versatility.
What makes this journey particularly exciting is how much we still don’t know. As analytical techniques improve and research expands globally, we’re likely to discover cannabinoids with properties we haven’t even imagined. The compounds that seem minor today may prove to be tomorrow’s breakthrough medicines.
For those navigating the world of cannabis – whether as patients, practitioners, or advocates – understanding these cannabinoids provides a foundation for making informed decisions. Each compound tells its own story, from CBN’s accidental discovery in 1896 as the first isolated cannabinoid to the shocking potency of THCP discovered just five years ago. Together, they paint a picture of a plant that has evolved alongside humanity, offering an ever-expanding pharmacopeia of natural compounds.
The cannabis plant has been humanity’s companion for millennia, but we’re only now beginning to truly understand its gifts. As we continue to explore these remarkable molecules, one thing remains certain: the more we learn about cannabinoids, the more we realize how much more there is to discover.
Thanks for reading!